Tracked deals
4
4 tracked deals across 2023-2025.
Operating Company
Healthcare
Pinnacle Clinical Research
San Antonio, Texas, United States
A premier clinical research network specializing in high-quality, patient-focused multi-site clinical trials, with particular expertise in liver disease/metabolic disorders and memory loss/neurodegenerative conditions.
- Focus Areas
- Clinical research network / site management, Liver disease / metabolic disorders, Memory loss / neurodegenerative conditions
- Website
- www.pinnacleresearch.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
4 addon
Pinnacle Clinical Research Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
- Buyer
- Summit Clinical Research, Pinnacle Clinical Research, LongueVue Capital
- Target
- Houston Research Institute
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.
-
September 27, 2024
- Buyer
- Pinnacle Clinical Research, LongueVue Capital
- Target
- Jubilee Clinical Research, Inc.
- Industry
- Healthcare Services
- Location
- Nevada, United States
- Type
- Addon
LongueVue Capital-backed Pinnacle Clinical Research has acquired Jubilee Clinical Research, a Las Vegas-based multi-therapeutic clinical trial site focused on metabolic and cardiovascular indications. The add-on expands Pinnacle's West Coast footprint and therapeutic expertise; Jubilee's founder Dr. Elliot Shin will continue to lead the site within the Pinnacle network.
-
June 18, 2024
- Buyer
- Pinnacle Clinical Research, LongueVue Capital
- Target
- Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research - Low Country, Dallas Research Institute
- Industry
- Healthcare Services
- Location
- United States
- Type
- Addon
Pinnacle Clinical Research, a portfolio company of LongueVue Capital, has acquired or partnered with five clinical research sites — Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute — expanding Pinnacle’s network to 12 U.S. sites. The transactions broaden Pinnacle’s geographic footprint and add CNS/Alzheimer’s and metabolic disease capabilities, strengthening the platform’s ability to serve sponsors and underrepresented patient populations.
-
January 10, 2023
- Buyer
- Pinnacle Clinical Research, LongueVue Capital
- Target
- South Texas Research Institute
- Industry
- Healthcare Services
- Location
- Texas, United States
- Type
- Addon
Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.
Related Acquisition Pages
Selling a company? Get in front of buyers like Pinnacle Clinical Research
Turn tracked acquisition activity into an outreach-ready buyer list.